Although most national guidelines for the diagnosis and management of hypertension emphasize that the initiation and modification of blood pressure (BP)-lowering treatment should be related to absolute cardiovascular disease (CVD) risk, there is only limited information on how to incorporate ambulatory BP (ABP) monitoring into this framework. The objective of this initiative is to provide ABP equivalents for BP cut-points for treatment initiation and targets to be included into guidelines.
Head, G. A., McGrath, B. P., Mihailidou, A. S., Nelson, M. R., Schlaich, M. P., Stowasser, M., Mangoni, A. A., Cowley, D., Brown, M. A., Ruta, L-A., & Wilson, A. (2012). Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. Journal of Hypertension, 30(2), 253-266. https://doi.org/10.1097/HJH.0b013e32834de621